• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Keryx Biopharmaceuticals

Keryx Biopharmaceuticals

Keryx Biopharmaceuticals Inc KERX

Last Price$4.10Day Change (%)-3.53%
Open Price$4.22Day Change ($)-0.15
Day Range4.06–4.3552-Week Range2.80–7.80

As of Wed 8/31/2016 5:00:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. KERX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Keryx Biopharmaceuticals , Inc. and a Lead Plaintiff Deadline of October 3, 2016

    KERX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Keryx Biopharmaceuticals , Inc. and a Lead Plaintiff Deadline of October 3, 2016

  2. Robbins Arroyo LLP: Keryx Biopharmaceuticals , Inc. (KERX ) Misled Shareholders According to a Recently Filed Class Action

    Robbins Arroyo LLP: Keryx Biopharmaceuticals , Inc. ( KERX ) Misled Shareholders According to a Recently Filed Class Action

  3. SHAREHOLDER ALERT: Rosen Law Firm Reminds Keryx Biopharmaceuticals Inc. Investors of Important Deadline in Class Action - KERX

    SHAREHOLDER ALERT: Rosen Law Firm Reminds Keryx Biopharmaceuticals Inc. Investors of Important Deadline in Class Action - KERX

  4. INVESTOR ALERT: Class Action Lawsuit on Behalf of Investors in Keryx Biopharmaceuticals Announced by Holzer & Holzer

    INVESTOR ALERT: Class Action Lawsuit on Behalf of Investors in Keryx Biopharmaceuticals Announced by Holzer & Holzer

  5. INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm

    INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm

  6. EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Keryx Biopharmaceuticals Inc.

    EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Keryx Biopharmaceuticals Inc.

  7. INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Keryx Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In ...

    INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Keryx Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

  8. The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Keryx Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm

    The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Keryx Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm

  9. Glancy Prongay & Murray Commences Investigation on Behalf of Keryx Pharmaceuticals, Inc. Investors

    Glancy Prongay & Murray Commences Investigation on Behalf of Keryx Pharmaceuticals, Inc. Investors

  10. Five Consensus Views that Could Prove Wrong in 2015

    Options on this firm's blockbuster cost a little but pay off big.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.